The Cleveland Clinic announced its choice of top ten heath industry innovations that will have a major impact in 2015. The number one-ranked health care powerhouse made the announcement during its summit in October 2014. A Mobile Stroke Treatment Unit Almost 800,000...
Every industry is seeking ways to harness and use Big Data effectively including the pharmaceutical industry. According to Nick de Cent of EyeforPharma, at issue for the health care industry is the availability of “open data” that can be easily accessed in a shareable...
The length of time that it takes for drugs to be approved, or whether they are approved at all, affects stakeholders. These stakeholders include patients who may benefit from the drugs, potential investors who shore up the pharmaceutical industry, and the companies...
A paradigm shift may be imminent concerning the development and commercialization of pharma products and new medicines, according to Ulrich Neumann of Eyeforpharma. Neumann discusses the idea that the clinical trial process to bring new drugs to market should become...
The first six months of 2014 have seen as many pharmaceutical initial public offerings as the whole of 2013. A total of 52 IPOs have been completed in 2014, whereas 2013 saw a total of 54 IPOs. The industry is experiencing heightened investment activity now that the...
The media hub, Eye for Pharma, has reported on the new relaxed rules concerning the export of drugs to the European Union (EU). Additional documentation is no longer required by exporting pharma companies because the US has been granted “listed” country status by the...